1. Home
  2. ALLO vs NVEC Comparison

ALLO vs NVEC Comparison

Compare ALLO & NVEC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • ALLO
  • NVEC
  • Stock Information
  • Founded
  • ALLO 2017
  • NVEC 1989
  • Country
  • ALLO United States
  • NVEC United States
  • Employees
  • ALLO N/A
  • NVEC N/A
  • Industry
  • ALLO Biotechnology: Biological Products (No Diagnostic Substances)
  • NVEC Semiconductors
  • Sector
  • ALLO Health Care
  • NVEC Technology
  • Exchange
  • ALLO Nasdaq
  • NVEC Nasdaq
  • Market Cap
  • ALLO 338.9M
  • NVEC 347.3M
  • IPO Year
  • ALLO 2018
  • NVEC 1996
  • Fundamental
  • Price
  • ALLO $1.44
  • NVEC $63.63
  • Analyst Decision
  • ALLO Strong Buy
  • NVEC
  • Analyst Count
  • ALLO 10
  • NVEC 0
  • Target Price
  • ALLO $9.66
  • NVEC N/A
  • AVG Volume (30 Days)
  • ALLO 3.3M
  • NVEC 18.8K
  • Earning Date
  • ALLO 05-12-2025
  • NVEC 04-30-2025
  • Dividend Yield
  • ALLO N/A
  • NVEC 6.35%
  • EPS Growth
  • ALLO N/A
  • NVEC N/A
  • EPS
  • ALLO N/A
  • NVEC 3.10
  • Revenue
  • ALLO $22,000.00
  • NVEC $25,688,208.00
  • Revenue This Year
  • ALLO N/A
  • NVEC N/A
  • Revenue Next Year
  • ALLO $8.30
  • NVEC N/A
  • P/E Ratio
  • ALLO N/A
  • NVEC $20.50
  • Revenue Growth
  • ALLO N/A
  • NVEC N/A
  • 52 Week Low
  • ALLO $1.30
  • NVEC $62.50
  • 52 Week High
  • ALLO $4.30
  • NVEC $89.98
  • Technical
  • Relative Strength Index (RSI)
  • ALLO 36.16
  • NVEC 35.45
  • Support Level
  • ALLO $1.49
  • NVEC $62.96
  • Resistance Level
  • ALLO $1.69
  • NVEC $68.46
  • Average True Range (ATR)
  • ALLO 0.14
  • NVEC 1.77
  • MACD
  • ALLO -0.03
  • NVEC 0.00
  • Stochastic Oscillator
  • ALLO 17.50
  • NVEC 18.96

About ALLO Allogene Therapeutics Inc.

Allogene Therapeutics Inc is a clinical-stage biotech firm specializing in immuno-oncology, focusing on the development of genetically engineered allogeneic T-cell products for cancer and autoimmune diseases. Their pipeline includes off-the-shelf T-cell candidates designed to target cancer cells or autoreactive cells in autoimmune disorders. Notably, their allogeneic approach, derived from healthy donors, allows for broader patient eligibility and scalability. With a vision to redefine CAR T therapy, the company concentrates on core programs targeting lymphoma, leukemia, autoimmune diseases, and solid tumors. Revenue, generated from collaborations and licensing agreements, supports their research and development efforts.

About NVEC NVE Corporation

NVE Corp develops and sells devices that use spintronics, a nanotechnology that relies on electron spin. It manufactures high-performance spintronic products including sensors and couplers that are used to acquire and transmit data. The company's products include Digital sensors, Medical sensors, Rotation Sensors, GT Sensors, Angle Sensors, Analog sensors, MSOP Isolators, Passive-In Transceivers, and others. The company manufactures high-performance spintronic products including sensors and couplers. The company's designs are based on giant magnetoresistance GMR and tunneling magnetoresistance TMR combined with integrated circuitry.

Share on Social Networks: